Technical Analysis for RZLT - Rezolute, Inc.

Grade Last Price % Change Price Change
C 5.01 1.21% 0.06
RZLT closed up 1.21 percent on Wednesday, November 20, 2024, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Below Lower BB Weakness 1.21%
Lower Bollinger Band Touch Weakness 1.21%
Oversold Stochastic Weakness 1.21%
Fell Below 50 DMA Bearish 2.87%
Expansion Pivot Sell Setup Bearish Swing Setup 2.87%
Stochastic Reached Oversold Weakness 2.87%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 18 hours ago
Up 3% about 21 hours ago
60 Minute Opening Range Breakout about 21 hours ago
Rose Above Previous Day's High about 21 hours ago
Up 2% about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for rare and metabolic diseases in the United States. Its products include RZ358, a human monoclonal antibody that is in Phase II clinical trial for the treatment of congenital hyperinsulinism, a devastating ultra-orphan pediatric disease; and RZ402, a plasma kallikrein inhibitor, which is in late stage preclinical program for the treatment of diabetic macular edema. It also develops AB101, a human recombinant insulin, which is in Phase I clinical trial for the treatment of patients with type 1 and type 2 diabetes mellitus. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Diabetes Cancer Treatment Monoclonal Antibody Metabolic Disease Insulin Specialty Drugs Diabetes Mellitus Diabetic Retinopathy Macular Edema Diabetic Macular Edema Kallikrein Plasma Kallikrein

Is RZLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.1856
52 Week Low 0.72
Average Volume 398,589
200-Day Moving Average 3.82
50-Day Moving Average 5.14
20-Day Moving Average 5.51
10-Day Moving Average 5.44
Average True Range 0.38
RSI (14) 42.53
ADX 22.88
+DI 15.96
-DI 22.41
Chandelier Exit (Long, 3 ATRs) 5.04
Chandelier Exit (Short, 3 ATRs) 5.81
Upper Bollinger Bands 6.08
Lower Bollinger Band 4.94
Percent B (%b) 0.06
BandWidth 20.65
MACD Line 0.01
MACD Signal Line 0.12
MACD Histogram -0.1102
Fundamentals Value
Market Cap 198.52 Million
Num Shares 39.6 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -4.55
Price-to-Sales 0.00
Price-to-Book 0.38
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.43
Resistance 3 (R3) 5.43 5.28 5.36
Resistance 2 (R2) 5.28 5.17 5.28 5.34
Resistance 1 (R1) 5.15 5.11 5.21 5.15 5.31
Pivot Point 5.00 5.00 5.03 5.00 5.00
Support 1 (S1) 4.86 4.89 4.93 4.87 4.71
Support 2 (S2) 4.72 4.83 4.72 4.68
Support 3 (S3) 4.58 4.72 4.66
Support 4 (S4) 4.59